Grant: Discovery Grants Program - Individual
The University of Western Ontario
$24,000.00
Heterogeneous data fusion and machine learning for image understanding in lung cancer
EF 2023-24
Résumé
Lung cancer remains the most common cause of cancer death worldwide. For patients with early-stage non-small cell lung cancer, where the tumour is small (less than 5 cm) and has not spread to other parts of the body, standard treatment is either surgery or high-dose radiation therapy. However, even when these cancers are diagnosed at an early-stage, up to half of patients may develop a recurrence after treatment, in which the cancer returns at the same spot or somewhere else in the body. One of the major problems with lung cancer is determining which patients will be cured of their disease following treatment. To solve this problem, this research proposes to develop a novel software tool to aid physicians in determining which patients are at a higher risk of recurrence following treatment. Prior to treatment patients receive imaging to determine the extent of their disease, including computed tomography (CT) and position emission tomography (PET). However, physicians typically only measure the diameter of the tumour on CT and look for areas where the cancer has spread on PET. We propose to develop an artificially intelligent computer system to help physicians extract more information from these medical images. A new area of artificial intelligence, known as deep learning is a type of artificial neural network, which is a software program that mimics the structure and function of biological neurons, such as those in the brain. Deep learning has shown promise in many areas of medicine, including understanding imaging data. We will develop a deep learning based artificial intelligence software system to integrate medical imaging and the non-imaging patient data to predict which patients are at a higher risk of treatment failure. A deep learning system can extract subtle features within the image, that may not be visible by the physician's eye, and combine it with other patient information. This model will integrate multi-modal and multi-scale information, including 3-dimensional medical imaging data (CT and PET), clinical parameters (e.g., age, smoking history), blood parameters, and tumour genomic information. This software system will integrate multiple sources of information about a patient and provide the physician with a prognosis for the patient, or a probability that the standard treatment will cure the patient's cancer. We will also develop, for the first time, a novel graphical user interface to visualize and display this information to the physician. Overall, the software tool developed within this research program will enable accurate computer-aided prognosis based on different types of lung imaging data and the integration of clinical, blood, and genomic information about a patient. This non-invasive and inexpensive software tool will allow for better prognostic characterization of lung cancer that can help physicians in identifying patients at higher risk of recurrence for indicating more aggressive or personalized treatment options.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2020-06498
Name nom
Mattonen, Sarah
Department département
Department of Medical Biophysics
Organization id
36
Institution établissement
The University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2020
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical technology
Research subject en
Génie biomédical
Research subject fr
Technologie biomédicale
Application title
Heterogeneous data fusion and machine learning for image understanding in lung cancer
Keyword
Computed tomography; Computer aided prognosis; Deep learning; Lung cancer; Machine learning; Medical image analysis; Medical imaging; Positron emission tomography; Quantitative imaging
Application summary
Lung cancer remains the most common cause of cancer death worldwide. For patients with early-stage non-small cell lung cancer, where the tumour is small (less than 5 cm) and has not spread to other parts of the body, standard treatment is either surgery or high-dose radiation therapy. However, even when these cancers are diagnosed at an early-stage, up to half of patients may develop a recurrence after treatment, in which the cancer returns at the same spot or somewhere else in the body. One of the major problems with lung cancer is determining which patients will be cured of their disease following treatment. To solve this problem, this research proposes to develop a novel software tool to aid physicians in determining which patients are at a higher risk of recurrence following treatment. Prior to treatment patients receive imaging to determine the extent of their disease, including computed tomography (CT) and position emission tomography (PET). However, physicians typically only measure the diameter of the tumour on CT and look for areas where the cancer has spread on PET. We propose to develop an artificially intelligent computer system to help physicians extract more information from these medical images. A new area of artificial intelligence, known as deep learning is a type of artificial neural network, which is a software program that mimics the structure and function of biological neurons, such as those in the brain. Deep learning has shown promise in many areas of medicine, including understanding imaging data. We will develop a deep learning based artificial intelligence software system to integrate medical imaging and the non-imaging patient data to predict which patients are at a higher risk of treatment failure. A deep learning system can extract subtle features within the image, that may not be visible by the physician's eye, and combine it with other patient information. This model will integrate multi-modal and multi-scale information, including 3-dimensional medical imaging data (CT and PET), clinical parameters (e.g., age, smoking history), blood parameters, and tumour genomic information. This software system will integrate multiple sources of information about a patient and provide the physician with a prognosis for the patient, or a probability that the standard treatment will cure the patient's cancer. We will also develop, for the first time, a novel graphical user interface to visualize and display this information to the physician. Overall, the software tool developed within this research program will enable accurate computer-aided prognosis based on different types of lung imaging data and the integration of clinical, blood, and genomic information about a patient. This non-invasive and inexpensive software tool will allow for better prognostic characterization of lung cancer that can help physicians in identifying patients at higher risk of recurrence for indicating more aggressive or personalized treatment options.